CIK: 0001615982 · Show all filings
Period: Q1 2022 (← Previous) (Next →)
Filing Date: May 16, 2022
Total Value ($000): $617,244 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 4,563,962 | $78,683 | 12.7% | $13.57 | +0.5% | COM | 00461U105 |
| — | Instil Bio Inc | 6,865,076 | $73,800 | 12.0% | $25.08 | — | COM | 45783C101 |
| RLMD | Relmada Therapeutics Inc | 2,270,072 | $61,269 | 9.9% | $31.54 | -34.4% | COM | 75955J402 |
| TVTX | Travere Therapeutics Inc | 1,994,997 | $51,411 | 8.3% | $19.66 | +35.0% | COM | 89422G107 |
| GHRS | GH Research PLC | 2,051,060 | $37,514 | 6.1% | $20.66 | -14.5% | ORD SH | G3855L106 |
| — | Tricida Inc | 4,494,851 | $36,948 | 6.0% | $8.83 | — | COM | 89610F101 |
| VRDN | Viridian Therapeutics Inc | 1,852,919 | $34,260 | 5.6% | $18.59 | +3.4% | COM | 92790C104 |
| — | Marinus Pharmaceuticals Inc | 3,156,803 | $29,516 | 4.8% | $11.98 | — | COM | 56854Q200 |
| CLDX | Celldex Therapeutics Inc | 865,116 | $29,466 | 4.8% | $15.71 | +103.5% | COM | 15117B202 |
| WHWK | Aadi Bioscience Inc | 1,529,402 | $25,954 | 4.2% | $30.48 | -37.1% | COM | 00032Q104 |
| — | Chinook Therapeutics Inc | 1,283,821 | $21,003 | 3.4% | $16.31 | — | COM | 16961L106 |
| LIANY | LianBio | 5,378,341 | $19,954 | 3.2% | $6.16 | — | SPONS ADR | 53000N108 |
| — | VistaGen Therapeutics Inc | 16,047,286 | $19,899 | 3.2% | $2.02 | — | COM | 92840H202 |
| — | Athira Pharma Inc | 1,000,000 | $13,500 | 2.2% | $20.05 | — | COM | 04746L104 |
| — | Eiger BioPharmaceuticals Inc | 1,469,767 | $12,199 | 2.0% | $8.30 | — | COM | 28249U105 |
| NUVL | Nuvalent Inc | 803,951 | $11,167 | 1.8% | $29.01 | -49.9% | COM | 670703107 |
| — | Graphite Bio Inc | 1,612,617 | $8,224 | 1.3% | $30.73 | — | COM | 38870X104 |
| — | Provention Bio Inc | 1,118,653 | $8,189 | 1.3% | $7.32 | — | COM | 74374N102 |
| COGT | Cogent Biosciences Inc | 1,088,817 | $8,155 | 1.3% | $10.99 | -36.6% | COM | 19240Q201 |
| ATYR | aTyr Pharma Inc | 1,398,889 | $7,484 | 1.2% | $5.98 | -5.3% | COM | 002120202 |
| — | Affimed NV | 1,428,571 | $6,243 | 1.0% | $5.52 | — | COM | N01045108 |
| — | Sierra Oncology Inc | 162,479 | $5,207 | 0.8% | $32.05 | — | COM | 82640U404 |
| ALT | Altimmune Inc | 759,719 | $4,627 | 0.7% | $7.36 | 0.0% | COM | 02155H200 |
| CNTA | Centessa Pharmaceuticals PLC | 411,361 | $3,690 | 0.6% | $22.21 | — | SPONS ADR | 152309100 |
| — | Astria Therapeutics Inc | 538,999 | $3,617 | 0.6% | $8.84 | — | COM | 04635X102 |
| — | Aerovate Therapeutics Inc | 151,037 | $2,769 | 0.4% | $18.33 | — | COM | 008064107 |
| SVRA | Savara Inc | 1,905,265 | $2,496 | 0.4% | $1.20 | 0.0% | COM | 805111101 |